Market Tracker

06/28 4:34am ET

ImmuCell Corp (NASDAQ:ICCC)

7.05
Delayed Data
As of Jun 27
 +0.06 / +0.86%
Today’s Change
4.76
Today|||52-Week Range
8.24
+18.49%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.99
Today’s open6.76
Day’s range6.52 - 7.05
Volume42,473
Average volume (3 months)6,243
Market cap$33.9M
Dividend yield--
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio58.8
Price/Sales2.70
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
BPMXBiopharmx Corp+0.01+1.40%
AZRXAzurRx BioPharma Inc+0.21+5.54%
CSBRChampions Oncology I...+0.05+1.77%
BPTHBio Path Holdings In...+0.00+0.87%
Data as of 06/27/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts